论文部分内容阅读
我院于1975年2月开始把卫矛应用于临床,并对其中100例冠心病心绞痛患者,进行疗效观察。现将结果报告如下。一、一般临床资料本组病例均按1974年全国修订的冠心病诊断标准确诊后选定,其中住院患者11人,防治点患者12人,门诊患者77人。性别:男性66人,女性34人,二者之比为1.94:1,男多于女。年令:最大年令为76岁,最小者28岁,平均年令为51.3岁,年令在41—60岁之间者占全组的76％。病程最长者为12年,最短者为3个月。合并症:合并高血压病者占45％,陈旧性心肌梗塞占8％。
Our hospital in February 1975 began to Weiyou applied to clinical, and of which 100 cases of patients with angina pectoris, the efficacy of observation. The results reported below. First, the general clinical data of this group of patients were diagnosed in accordance with the revised national standards of coronary heart disease in 1974 selected after diagnosis, including 11 inpatients, prevention and treatment of 12 patients, 77 outpatients. Sex: 66 males and 34 females, the ratio of 1.94: 1, more men than women. Year: The maximum year is 76 years, the youngest 28 years old, the average annual age is 51.3 years, accounting for 76% of the group between the ages of 41-60. The longest course of 12 years, the shortest of 3 months. Complications: Hypertensive patients with 45%, old myocardial infarction accounted for 8%.